Cargando…
PB2625: VAYHIT2: A RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL OF IANALUMAB VS PLACEBO IN ADDITION TO ELTROMBOPAG IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) WHO FAILED FIRST-LINE STEROID TREATMENT
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429596/ http://dx.doi.org/10.1097/01.HS9.0000977188.95345.32 |
| _version_ | 1785090754434039808 |
|---|---|
| author | Zaja, Francesco Al-Samkari, Hanny Michel, Marc Ghanima, Waleed Cooper, Nichola Wong, Raymond Barcellini, Wilma Zhang, Fengkui Marturano, Emerenziana Peyrard, Severine Cuker, Adam |
| author_facet | Zaja, Francesco Al-Samkari, Hanny Michel, Marc Ghanima, Waleed Cooper, Nichola Wong, Raymond Barcellini, Wilma Zhang, Fengkui Marturano, Emerenziana Peyrard, Severine Cuker, Adam |
| author_sort | Zaja, Francesco |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429596 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104295962023-08-17 PB2625: VAYHIT2: A RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL OF IANALUMAB VS PLACEBO IN ADDITION TO ELTROMBOPAG IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) WHO FAILED FIRST-LINE STEROID TREATMENT Zaja, Francesco Al-Samkari, Hanny Michel, Marc Ghanima, Waleed Cooper, Nichola Wong, Raymond Barcellini, Wilma Zhang, Fengkui Marturano, Emerenziana Peyrard, Severine Cuker, Adam Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429596/ http://dx.doi.org/10.1097/01.HS9.0000977188.95345.32 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Zaja, Francesco Al-Samkari, Hanny Michel, Marc Ghanima, Waleed Cooper, Nichola Wong, Raymond Barcellini, Wilma Zhang, Fengkui Marturano, Emerenziana Peyrard, Severine Cuker, Adam PB2625: VAYHIT2: A RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL OF IANALUMAB VS PLACEBO IN ADDITION TO ELTROMBOPAG IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) WHO FAILED FIRST-LINE STEROID TREATMENT |
| title | PB2625: VAYHIT2: A RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL OF IANALUMAB VS PLACEBO IN ADDITION TO ELTROMBOPAG IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) WHO FAILED FIRST-LINE STEROID TREATMENT |
| title_full | PB2625: VAYHIT2: A RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL OF IANALUMAB VS PLACEBO IN ADDITION TO ELTROMBOPAG IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) WHO FAILED FIRST-LINE STEROID TREATMENT |
| title_fullStr | PB2625: VAYHIT2: A RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL OF IANALUMAB VS PLACEBO IN ADDITION TO ELTROMBOPAG IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) WHO FAILED FIRST-LINE STEROID TREATMENT |
| title_full_unstemmed | PB2625: VAYHIT2: A RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL OF IANALUMAB VS PLACEBO IN ADDITION TO ELTROMBOPAG IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) WHO FAILED FIRST-LINE STEROID TREATMENT |
| title_short | PB2625: VAYHIT2: A RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL OF IANALUMAB VS PLACEBO IN ADDITION TO ELTROMBOPAG IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) WHO FAILED FIRST-LINE STEROID TREATMENT |
| title_sort | pb2625: vayhit2: a randomized, double-blind, phase iii trial of ianalumab vs placebo in addition to eltrombopag in patients with primary immune thrombocytopenia (itp) who failed first-line steroid treatment |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429596/ http://dx.doi.org/10.1097/01.HS9.0000977188.95345.32 |
| work_keys_str_mv | AT zajafrancesco pb2625vayhit2arandomizeddoubleblindphaseiiitrialofianalumabvsplaceboinadditiontoeltrombopaginpatientswithprimaryimmunethrombocytopeniaitpwhofailedfirstlinesteroidtreatment AT alsamkarihanny pb2625vayhit2arandomizeddoubleblindphaseiiitrialofianalumabvsplaceboinadditiontoeltrombopaginpatientswithprimaryimmunethrombocytopeniaitpwhofailedfirstlinesteroidtreatment AT michelmarc pb2625vayhit2arandomizeddoubleblindphaseiiitrialofianalumabvsplaceboinadditiontoeltrombopaginpatientswithprimaryimmunethrombocytopeniaitpwhofailedfirstlinesteroidtreatment AT ghanimawaleed pb2625vayhit2arandomizeddoubleblindphaseiiitrialofianalumabvsplaceboinadditiontoeltrombopaginpatientswithprimaryimmunethrombocytopeniaitpwhofailedfirstlinesteroidtreatment AT coopernichola pb2625vayhit2arandomizeddoubleblindphaseiiitrialofianalumabvsplaceboinadditiontoeltrombopaginpatientswithprimaryimmunethrombocytopeniaitpwhofailedfirstlinesteroidtreatment AT wongraymond pb2625vayhit2arandomizeddoubleblindphaseiiitrialofianalumabvsplaceboinadditiontoeltrombopaginpatientswithprimaryimmunethrombocytopeniaitpwhofailedfirstlinesteroidtreatment AT barcelliniwilma pb2625vayhit2arandomizeddoubleblindphaseiiitrialofianalumabvsplaceboinadditiontoeltrombopaginpatientswithprimaryimmunethrombocytopeniaitpwhofailedfirstlinesteroidtreatment AT zhangfengkui pb2625vayhit2arandomizeddoubleblindphaseiiitrialofianalumabvsplaceboinadditiontoeltrombopaginpatientswithprimaryimmunethrombocytopeniaitpwhofailedfirstlinesteroidtreatment AT marturanoemerenziana pb2625vayhit2arandomizeddoubleblindphaseiiitrialofianalumabvsplaceboinadditiontoeltrombopaginpatientswithprimaryimmunethrombocytopeniaitpwhofailedfirstlinesteroidtreatment AT peyrardseverine pb2625vayhit2arandomizeddoubleblindphaseiiitrialofianalumabvsplaceboinadditiontoeltrombopaginpatientswithprimaryimmunethrombocytopeniaitpwhofailedfirstlinesteroidtreatment AT cukeradam pb2625vayhit2arandomizeddoubleblindphaseiiitrialofianalumabvsplaceboinadditiontoeltrombopaginpatientswithprimaryimmunethrombocytopeniaitpwhofailedfirstlinesteroidtreatment |